FDA approval for Pfizer COVID shot slightly impacted vaccine numbers

In subsequent weeks since approval, demand has fallen

FILE - In this Tuesday, Sept. 21, 2021 file photo, a nurse loads a syringe with the Pfizer COVID-19 vaccine in Jackson, Miss. Millions of Americans are now eligible to receive a Pfizer booster shot to help increase their protection against the worst effects of the coronavirus. (AP Photo/Rogelio V. Solis) (Rogelio V. Solis, Copyright 2021. The Associated Press. All rights reserved)

Remember those people who said they didn’t want to get COVID-19 vaccines that were not fully approved by the Food and Drug Administration?

Vaccination numbers appear to indicate that approval didn’t change many of their minds.

[TRENDING: Tropical wave could bring rain to Fla. | Roommate fight leaves 1 dead, 2 hurt | Become a News 6 Insider]

Pfizer saw an increase in demand for its vaccine after it received full FDA approval, but it was modest and short-lived.

In the week following that full approval, Pfizer vaccination rates rose by 16%.

During the same time, rates for Moderna’s vaccine, which still only has emergency use approval, rose by 5%.

In subsequent weeks, demand for both has fallen.